|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 25.21 USD | -1.56% |
|
-1.98% | +9.61% |
| 08-20 | Ultragenyx Pharmaceutical Inc. - Special Call | |
| 08-19 | Ultragenyx Pharmaceutical Receives Accelerated US FDA Approval for Genglycos | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
RARE 25.21 $
-1.56%
48.76M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| RARE | 25.21USD | -1.56% | 48.76M $ | |
CBOE
| RARE | 25.19USD | -1.60% | 1.43M $ | |
|
Boerse Muenchen
| UP0 | 21.58EUR | -2.62% | 3.45K € | |
|
Tradegate
| UP0 | 21.69EUR | -1.90% | 3.34K € | |
|
London S.E.
| 0LIF | 24.57USD | -31.52% | 368.55 $ | |
|
Mexican S.E.
| RARE * | 450.00MXN | -60.89% | 6.3K $ | |
|
Deutsche Boerse AG
| UP0 | 21.95EUR | -0.95% | 0 € | |
|
Börse Stuttgart
| UP0 | 21.57EUR | -1.55% | 0 € | |
|
Berne S.E.
| UP0 | 21.08CHF | +0.70% | 0 CHF | |
Sao Paulo
| R2AR34 | 13.39BRL | +0.45% | 6.7K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 28.62 | 35.87 | 36.38 |
| Spread/Res. | -11.91% | -29.72% | -30.70% |
| Spread/Supp. | +1.20% | +36.27% | +30.08% |
| Support | 24.91 | 18.5 | 19.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RARE Stock
- Charts Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
